Novartis

Driving the business back to health

Five years ago, Swiss multinational pharmaceutical company, Novartis, were facing a challenge. Customer service levels in its patented Innovative Medicines division had fallen and too many products were out of stock on a daily basis. In order to ensure the availability of vital medicines to patients, the company decided to act. It embarked on a Class A program with Oliver Wight to transform the supply side of the business. Find out what happened on their journey.